Vimarsana
Biggest News Aggregation in the World

Roger Meier News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Roger Meier. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Roger Meier Today - Breaking & Trending Today

Virtual conference information for Middle Eastern Cement conference & exhibition - Vimarsana News

Virtual conference information for Middle Eastern Cement conference & exhibition

Global Cement online portal for all things cement related

Virtual conference information for Middle Eastern Cement conference & exhibition - Vimarsana News

Virtual conference information for Middle Eastern Cement conference & exhibition

Virtual conference information for Middle Eastern Cement Conference

Collaboration brings DFU and Inflammatory Disease Therapy to Greater China Region - Vimarsana News

Collaboration brings DFU and Inflammatory Disease Therapy to Greater China Region

Aurealis Therapeutics, (Basel, Switzerland) and AI-based microbiome drug development company Xbiome have entered into an agreement for the clinical development and commercialisation of Aurealis’ investigational Diabetic Foot Ulcer (DFU) and other chronic wounds and inflammatory disease therapy in the Greater China territory. Click to read more...

Aurealis Therapeutics and Xbiome Enter into a License and Collaboration Agreement for Aurealis Four-in-One Diabetic Foot Ulcer and Inflammatory Disease Cell and Gene Therapy AUP-16 in Greater China - Vimarsana News

Aurealis Therapeutics and Xbiome Enter into a License and Collaboration Agreement for Aurealis Four-in-One Diabetic Foot Ulcer and Inflammatory Disease Cell and Gene Therapy AUP-16 in Greater China

/PRNewswire/ -- Aurealis Therapeutics, a synthetic biology company developing groundbreaking four-in-one cell and gene therapies and Xbiome, an AI-based...

Aurealis Therapeutics AG: Aurealis Therapeutics and Xbiome Enter into a License and Collaboration Agreement for Aurealis Four-in-One Diabetic Foot Ulcer and Inflammatory Disease Cell and Gene Therapy AUP-16 in Greater China - Vimarsana News

Aurealis Therapeutics AG: Aurealis Therapeutics and Xbiome Enter into a License and Collaboration Agreement for Aurealis Four-in-One Diabetic Foot Ulcer and Inflammatory Disease Cell and Gene Therapy AUP-16 in Greater China

BASEL, Switzerland, KUOPIO, Finland, and SHENZHEN, China, Jan. 28, 2022 /PRNewswire/ -- Aurealis Therapeutics, a synthetic biology company developing groundbreaking four-in-one cell and gene